Lionberger R - Search Results

1

Measurement of in vivo Gastrointestinal Release and Dissolution of Three Locally Acting Mesalamine Formulations in Regions of the Human Gastrointestinal Tract.

Yu A, Baker JR, Fioritto AF, Wang Y, Luo R, Li S, Wen B, Bly M, Tsume Y, Koenigsknecht MJ, Zhang X, Lionberger R, Amidon GL, Hasler WL, Sun D. Yu A, et al. Among authors: lionberger r. Mol Pharm. 2017 Feb 6;14(2):345-358. doi: 10.1021/acs.molpharmaceut.6b00641. Epub 2016 Dec 23. Mol Pharm. 2017. PMID: 28009518

2

Impact of P-glycoprotein-mediated intestinal efflux kinetics on oral bioavailability of P-glycoprotein substrates.

Kwon H, Lionberger RA, Yu LX. Kwon H, et al. Mol Pharm. 2004 Nov-Dec;1(6):455-65. doi: 10.1021/mp049921x. Mol Pharm. 2004. PMID: 16028357

3

Utility of physiologically based absorption modeling in implementing Quality by Design in drug development.

Zhang X, Lionberger RA, Davit BM, Yu LX. Zhang X, et al. AAPS J. 2011 Mar;13(1):59-71. doi: 10.1208/s12248-010-9250-9. Epub 2011 Jan 5. AAPS J. 2011. PMID: 21207216 Free PMC article.

4

The role of predictive biopharmaceutical modeling and simulation in drug development and regulatory evaluation.

Jiang W, Kim S, Zhang X, Lionberger RA, Davit BM, Conner DP, Yu LX. Jiang W, et al. Int J Pharm. 2011 Oct 14;418(2):151-60. doi: 10.1016/j.ijpharm.2011.07.024. Epub 2011 Jul 23. Int J Pharm. 2011. PMID: 21803144

5

Use of partial AUC to demonstrate bioequivalence of Zolpidem Tartrate Extended Release formulations.

Lionberger RA, Raw AS, Kim SH, Zhang X, Yu LX. Lionberger RA, et al. Pharm Res. 2012 Apr;29(4):1110-20. doi: 10.1007/s11095-011-0662-8. Epub 2012 Jan 26. Pharm Res. 2012. PMID: 22278753

6

Modeling and mechanistic approaches for oral absorption: quality by design in action.

Yu L, Zhang X, Lionberger R. Yu L, et al. Among authors: lionberger r. Ther Deliv. 2012 Feb;3(2):147-50. doi: 10.4155/tde.11.157. Ther Deliv. 2012. PMID: 22834193 No abstract available.

7

Modeling and simulation of the effect of proton pump inhibitors on magnesium homeostasis. 1. Oral absorption of magnesium.

Bai JP, Hausman E, Lionberger R, Zhang X. Bai JP, et al. Among authors: lionberger r. Mol Pharm. 2012 Dec 3;9(12):3495-505. doi: 10.1021/mp300323q. Epub 2012 Nov 2. Mol Pharm. 2012. PMID: 23051182

8

Innovative approaches for demonstration of bioequivalence: the US FDA perspective.

Zhang X, Zheng N, Lionberger RA, Yu LX. Zhang X, et al. Ther Deliv. 2013 Jun;4(6):725-40. doi: 10.4155/tde.13.41. Ther Deliv. 2013. PMID: 23738669 Review.

9

Modeling and simulation of biopharmaceutical performance.

Zhang X, Lionberger RA. Zhang X, et al. Among authors: lionberger ra. Clin Pharmacol Ther. 2014 May;95(5):480-2. doi: 10.1038/clpt.2014.40. Clin Pharmacol Ther. 2014. PMID: 24747237

10

Development of performance matrix for generic product equivalence of acyclovir topical creams.

Krishnaiah YS, Xu X, Rahman Z, Yang Y, Katragadda U, Lionberger R, Peters JR, Uhl K, Khan MA. Krishnaiah YS, et al. Among authors: lionberger r. Int J Pharm. 2014 Nov 20;475(1-2):110-22. doi: 10.1016/j.ijpharm.2014.07.034. Epub 2014 Jul 30. Int J Pharm. 2014. PMID: 25089511

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

79 results

Search Page

Filters